Editas Medicine, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
EDIT Nasdaq 2834 www.editasmedicine.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Editas Medicine, Inc.

Editas (EDIT) Upgraded to Buy: What Does It Mean for the Stock? - May 12th, 2025 4:00 pm
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May - May 5th, 2025 8:01 pm
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting - Apr 28th, 2025 8:31 pm
Editas Medicine, Inc. (NASDAQ:EDIT) institutional owners may be pleased with recent gains after 71% loss over the past year - Apr 23rd, 2025 11:50 am
Why Is Editas (EDIT) Down 37.1% Since Last Earnings Report? - Apr 4th, 2025 3:30 pm
AstraZeneca deepens China investment; Editas loses CFO to Dyne - Mar 21st, 2025 12:15 pm
Editas Medicine Announces Chief Financial Officer Transition - Mar 20th, 2025 8:01 pm
Here's Why Editas Medicine (NASDAQ:EDIT) Must Use Its Cash Wisely - Mar 13th, 2025 10:56 am
Editas Q4 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down - Mar 6th, 2025 3:09 pm
Editas Medicine (EDIT) Reports Q4 Loss, Misses Revenue Estimates - Mar 5th, 2025 10:25 pm
Editas: Q4 Earnings Snapshot - Mar 5th, 2025 9:19 pm
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates - Mar 5th, 2025 9:05 pm
Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Feb 24th, 2025 2:00 pm
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Feb 20th, 2025 3:00 pm
Editas Medicine Outlines 2025 Strategic Priorities and Milestones - Jan 14th, 2025 2:30 pm
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Jan 14th, 2025 2:00 pm
Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities - Jan 13th, 2025 2:00 pm
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? - Jan 8th, 2025 2:40 pm
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 6th, 2025 2:00 pm
Why Is Editas Medicine, Inc. (EDIT) Among the Top CRISPR Stocks to Invest In? - Dec 30th, 2024 8:11 pm